These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23574767)

  • 1. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.
    Kumakura S; Shibata H; Onoda K; Nishimura N; Matsuda C; Hirose M
    Epidemiol Infect; 2014 Jan; 142(1):12-9. PubMed ID: 23574767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.
    Kumakura S; Onoda K; Hirose M
    J Infect Chemother; 2014 Mar; 20(3):194-8. PubMed ID: 24462433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
    Asari S; Deguchi M; Tahara K; Taniike M; Toyokawa M; Nishi I; Watanabe M; Iwatani Y; Makimoto K
    Am J Infect Control; 2003 May; 31(3):157-62. PubMed ID: 12734521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
    Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    Ogawa T; Inoue T; Kasahara K; Konishi M; Mikasa K
    PLoS One; 2020; 15(3):e0230329. PubMed ID: 32208432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
    Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence for vaccine-preventable diseases among Italian healthcare workers.
    Coppeta L; D'Alessandro I; Pietroiusti A; Somma G; Balbi O; Iannuzzi I; Magrini A
    Hum Vaccin Immunother; 2021 May; 17(5):1342-1346. PubMed ID: 33017204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A
    Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
    Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel.
    Rosario-Rosario G; Gareca M; Kincaid H; Knouse MC
    J Travel Med; 2015; 22(6):396-402. PubMed ID: 26412393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare workers and measles-mumps-rubella (MMR) status: how worried should we be about further outbreaks?
    Basu S; Giri P; Adisesh A; McNAUGHT R
    Epidemiol Infect; 2014 Aug; 142(8):1688-94. PubMed ID: 24229805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007-2012.
    Kimura T; Tsunekawa K; Ogiwara T; Tokue Y; Nara M; Inoue T; Obuchi T; Suto C; Ohshima K; Murakami M
    Jpn J Infect Dis; 2013; 66(5):411-5. PubMed ID: 24047740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to measles, rubella, mumps, and varicella-zoster viruses among healthcare workers.
    Aypak C; Bayram Y; Eren H; Altunsoy A; Berktaş M
    J Nippon Med Sch; 2012; 79(6):453-8. PubMed ID: 23291844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain.
    Norman FF; Comeche B; Martínez-Lacalzada M; Pérez-Molina JA; Gullón B; Monge-Maillo B; Chamorro S; López-Vélez R
    J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33611577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T; McIntyre P; Roberton D; Descamps D
    Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
    Karadeniz A; Akduman Alaşehir E
    J Infect Public Health; 2020 Apr; 13(4):480-484. PubMed ID: 32113699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review.
    Hase R; Niiyama Y; Mito H
    Hum Vaccin Immunother; 2022 Dec; 18(1):1989922. PubMed ID: 34756159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.